Category list : Atrial fibrillation
Sort by: Newest first Oldest first A-Z Z-A
-
Anticoagulant antidote idarucizumab gets European regulator’s initial approval Subscription
Idarucizumab (Praxbind), a unique drug that can neutralise the effect of anticoagulant dabigatran etexilate (Pradaxa), has been recommended for marketing authorisation by the European medicines safety watchdog.
-
Anticoagulant prescribing for AF patients with high stroke risk more than doubles Subscription
GP prescribing of anticoagulants for the treatment of patients with atrial fibrillation and a high risk of stroke more than doubled between 2000 and 2016, from 35.4% to 75.5%, according to research published in July 2018.
-
Anticoagulants could cut the risk of dementia for patients with atrial fibrillation, researchers find
Oral anticoagulants are associated with a significant reduction in the risk of dementia in patients with atrial fibrillation (AF), according to a study published in the European Heart Journal.
-
Antihypertensives vary in ability to reduce atrial fibrillation risk
Calcium channel blockers are less effective at reducing hypertensive patients’ risk of developing atrial fibrillation (AF) than other classes of antihypertensive, including beta-blockers and angiotensin-converting enzyme inhibitors, a recent study suggests (Annals of Internal Medicine 2010;152:78).
-
Apixaban may be more effective and safer than rivaroxaban, research suggests Subscription
Adults with non-valvular atrial fibrillation prescribed apixaban have a lower rate of ischaemic stroke and systemic blood clots compared with those prescribed rivaroxaban, according to a retrospective cohort study in Annals of Internal Medicine.
-
Apixaban safer than warfarin for patients regardless of stroke history Subscription
Apixaban is associated with less major bleeding, death and hospitalisation than warfarin, regardless of a patient’s stroke history, a secondary analysis of the AUGUSTUS trial has indicated.
-
Atrial Fibrillation (1) The condition
The Pharmaceutical Journal Vol 264 No 7093p622-626April 22, 2000 Continuing educationAtrial Fibrillation(1) The condition by Gregory Y. H. Lip, MD, FRCPE and ...
-
Atrial fibrillation (2) Antiarrhythmic agents
The Pharmaceutical Journal Vol 264 No 7094p659-663April 29, 2000 Continuing educationAtrial fibrillation(2) Antiarrhythmic agentsBy Gregory Y. H. Lip, MD, ...
-
Atrial fibrillation (3) Antithrombotic therapy
The Pharmaceutical Journal Vol 264 No 7097p773-777May 20, 2000 Continuing educationAtrial fibrillation(3) Antithrombotic therapyBy Gregory Y. H. Lip, MD, FRCPE, ...
-
Atrial fibrillation (answers) Subscription
November 2010’s Lifelong Learning questions are based on the CLINICALFOCUS articles on Atrial fibrillationThe questions can be viewed/printedThis online module is closed
Show 10 per page20 per page50 per page
